Matthew C Kapusta

CIK 1536290 · CEO, Managing Director · last filed 2026-03-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$18.62M

Companies

3

Total Filings

79

Lifetime Open-Market Net

-$38.08M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QURE CEO, Managing Director 675,239 $27.57 $18.62M -$38.09M 66 2026-03-06
Decibel Therapeutics, Inc. (DBTX) Delisted Director 0 $4.91 $0 $0 2 2023-09-25
ANGIODYNAMICS INC (ANGO.V) Delisted SVP, Business Development 30,062 $11.4K 11 2014-11-19

Recent Filings · Page 5 of 8

79 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-07-24 QURE Sell (S) −5,626 -$238.0K EDGAR
2020-06-22 QURE Sell (S) −7,501 -$495.4K EDGAR
2020-05-22 QURE Sell (S) −7,501 -$449.6K EDGAR
2020-04-24 QURE Mixed -$462.6K EDGAR
2020-03-20 QURE Mixed -$191.0K EDGAR
2020-03-02 QURE Grant (A) +33,789 $0 EDGAR
2020-02-21 QURE Sell (S) −7,501 -$484.3K EDGAR
2020-01-31 QURE Sell (S) −51,038 -$3.08M EDGAR
2020-01-31 QURE Grant (A) +27,713 $0 EDGAR
2020-01-29 QURE Sell (S) −51,872 -$3.31M EDGAR
Showing 4150 of 79
Page 5 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.